Procter & Gamble stock holds near mid-$140s as fiscal 2026 results and restructuring shape outlook

Procter & Gamble Co. (ISIN US7427181091) stock is trading around the mid-$140s on the NYSE as of September 1, 2026, with recent data from one brokerage showing an intraday price of 144.82 USD that leaves the shares up about 1.6% from the session low and just under 1% below the intraday high on that date according to one real-time quote overview.

Fiscal 2026 figures and valuation context

For fiscal 2026, Procter & Gamble reported revenue of about 87 billion USD alongside net profit of roughly 16.1 billion USD and operating cash flow near 19.6 billion USD, as summarized in a recent corporate news overview that collated the company’s latest annual report data for investors looking at the most recent completed fiscal year through mid-2026 per a detailed fiscal 2026 summary.

The same overview notes that Procter & Gamble paid a dividend of around 4.35 USD per share on an annualized basis for the fiscal 2026 period, which implied a dividend yield in the region of 3% when the share price was about 143.71 USD as of August 30, 2026, 4:00 p.m. Eastern Time, illustrating a cash-return profile that many income-focused investors compare against other consumer staples names such as Johnson & Johnson when positioning their portfolios according to the same corporate news coverage.

Restructuring program and fiscal 2027 guidance

Beyond the core fiscal 2026 figures, Procter & Gamble is partway through a restructuring program that is expected to be largely completed by the end of fiscal 2027, with the company indicating that the total pretax cost of this reorganization should fall between 1 billion USD and 1.6 billion USD over roughly two years, creating a modest drag on near-term profitability but aiming to sharpen the focus of the brand portfolio according to a restructuring-focused analysis.

Recent commentary in that same analysis suggested that removing selected brands, formats and marketing approaches could reduce projected organic sales growth during the restructuring period by about 0.3 to 0.5 percentage points, meaning that investors need to factor in a slight headwind to top line momentum over the next two fiscal years even as management seeks to improve long-term efficiency and profitability through these changes, a trade-off that aligns with the company’s stated objective of balancing growth with margin stability.

Dividend profile and market capitalization

Income investors continue to pay close attention to Procter & Gamble’s dividend track record, with one recent sector comparison noting that the company paid 1.0885 USD per share on August 17, 2026, which translates into a forward annualized level of about 4.354 USD per share and underscores the stability of its cash returns relative to many peers, as highlighted in an analysis comparing Procter & Gamble’s dividend to another major healthcare and consumer peer.

On the market value side, a recent capitalization overview lists Procter & Gamble with a market cap of about 337.06 billion USD as of September 2026, a figure that places the company among the largest global consumer staples groups and gives it significant weight within major indices such as the S&P 500, while also underlining the scale at which its restructuring decisions and dividend policy can influence broad-based consumer equity funds according to a market capitalization overview.

Representative product: Tide and fabric care

Within its broad portfolio of household and personal care brands, Tide remains one of Procter & Gamble’s flagship fabric care products, serving as a key contributor to the company’s cleaning segment revenues and offering a concrete example of how brand strength supports the group’s pricing power and cash generation over time.

Stock level and investor takeaways

As of September 1, 2026, Procter & Gamble stock at 144.82 USD on the NYSE sits slightly above a recent closing level of 143.71 USD recorded on August 30, 2026, 4:00 p.m. Eastern Time, leaving the shares a bit below a consensus price target of 161.19 USD that implies a discount of about 17.48 USD, or more than 12%, between the market price and average analyst valuation according to the detailed corporate news overview cited earlier, a spread that investors weighing dividend yield against growth and restructuring headwinds will continue to monitor.